SPX3,818.83-2.72 -0.07%
DIA310.05+0.71 0.23%
IXIC11,177.89-3.65 -0.03%

--Wedbush Lifts Price Target on Day One Biopharmaceuticals to $35 From $32, Citing Tovorafenib Data; Outperform Rating Kept

MT Newswires · 06/13/2022 02:22

Please log in to view news